Literature DB >> 16917513

Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.

T Liu1, C Laurell, G Selivanova, J Lundeberg, P Nilsson, K G Wiman.   

Abstract

p53 triggers apoptosis in response to cellular stress. We analyzed p53-dependent gene and protein expression in response to hypoxia using wild-type p53-carrying or p53 null HCT116 colon carcinoma cells. Hypoxia induced p53 protein levels and p53-dependent apoptosis in these cells. cDNA microarray analysis revealed that only a limited number of genes were regulated by p53 upon hypoxia. Most classical p53 target genes were not upregulated. However, we found that Fas/CD95 was significantly induced in response to hypoxia in a p53-dependent manner, along with several novel p53 target genes including ANXA1, DDIT3/GADD153 (CHOP), SEL1L and SMURF1. Disruption of Fas/CD95 signalling using anti-Fas-blocking antibody or a caspase 8 inhibitor abrogated p53-induced apoptosis in response to hypoxia. We conclude that hypoxia triggers a p53-dependent gene expression pattern distinct from that induced by other stress agents and that Fas/CD95 is a critical regulator of p53-dependent apoptosis upon hypoxia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917513     DOI: 10.1038/sj.cdd.4402022

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  23 in total

Review 1.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

2.  Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.

Authors:  Rajan Gogna; Esha Madan; Periannan Kuppusamy; Uttam Pati
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

3.  Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.

Authors:  Jaime Torres; Paul L Regan; Robby Edo; Payton Leonhardt; Eric I Jeng; Eric F Rappaport; Naohiko Ikegaki; Xao X Tang
Journal:  Int J Oncol       Date:  2010-10       Impact factor: 5.650

4.  In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.

Authors:  Sangwon Cha; Marcin B Imielinski; Tomas Rejtar; Elizabeth A Richardson; Dipak Thakur; Dennis C Sgroi; Barry L Karger
Journal:  Mol Cell Proteomics       Date:  2010-08-25       Impact factor: 5.911

5.  Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin.

Authors:  Anurag Kumar Singh; Michael P Manns; Ursula Seidler
Journal:  Cell Mol Life Sci       Date:  2010-08-22       Impact factor: 9.261

6.  Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma.

Authors:  Paul L Regan; Joshua Jacobs; Gerald Wang; Jaime Torres; Robby Edo; Jennifer Friedmann; Xao X Tang
Journal:  Int J Oncol       Date:  2011-01       Impact factor: 5.650

7.  Relationship between expression of hepatocyte grow factor and apoptosis of trophoblasts in hypertensive disorder complicating pregnancy.

Authors:  Shan Ouyang; Fuyuan Qiao; Qinghua Zhang
Journal:  Front Med China       Date:  2007-10

8.  Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis.

Authors:  Hong-li Yan; Geng Xue; Qian Mei; Yu-zhao Wang; Fei-xiang Ding; Mo-Fang Liu; Ming-Hua Lu; Ying Tang; Hong-yu Yu; Shu-han Sun
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

9.  Cell-free DNA as a promising marker for risk stratification of pulmonary embolism.

Authors:  Evandro M Neto-Neves
Journal:  Crit Care       Date:  2013-11-19       Impact factor: 9.097

10.  Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.

Authors:  Alexandra Jauhiainen; Christer Thomsen; Linda Strömbom; Pernilla Grundevik; Carola Andersson; Anna Danielsson; Mattias K Andersson; Olle Nerman; Linda Rörkvist; Anders Ståhlberg; Pierre Åman
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.